Immuneering Corp. (IMRX) NASDAQ
$1.80 0.03 (1.70%)
Market Cap: $52.71M
As of 04/19/24 04:00 PM EDT. Market closed.
Immuneering Corp. (IMRX)
NASDAQ
$1.80
0.03 (1.70%)
Market Cap: $52.71M
As of 04/19/24 04:00 PM EDT. Market closed.
Add to Portfolio
COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
URL
Address
.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
URL
Address
.
PRICE CHART FOR IMMUNEERING CORP
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$1.77
Previous Close
$1.77
Days Range
$1.56 - $1.80
52 week range
$1.56 - $12.15
Volume
515,620
Avg. Volume (30 days)
653,334
Market Cap
$52.71M
Dividend Yield
-
P/E
(1.02)
Shares Outstanding
29,283,272
Open
$1.77
Previous Close
$1.77
Days Range
$1.56 - $1.80
52 week range
$1.56 - $12.15
Volume
515,620
Avg. Volume (30 days)
653,334
Market Cap
$52.71M
Dividend Yield
-
P/E
(1.02)
Shares Outstanding
29,283,272
FINANCIAL STATEMENTS FOR IMMUNEERING CORP
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR IMMUNEERING CORP
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Cormorant Asset Management, LP | 10% Owner | Apr 01, 2024 | Sale | $2.90 | 400,000 | 1,160,181 | 3,295,173 | Apr 03, 2024, 05:37 PM |
| Schall Thomas J. | Director | Mar 22, 2024 | Buy | $2.55 | 2,900 | 7,385 | 2,900 | Mar 25, 2024, 04:03 PM |
| Feinberg Peter | Director | Mar 22, 2024 | Buy | $2.55 | 25,000 | 63,713 | 111,766 | Mar 25, 2024, 09:13 AM |
| Brakewood Harold Eugene | Chief Business Officer | Mar 22, 2024 | Buy | $2.57 | 3,900 | 10,015 | 3,900 | Mar 25, 2024, 09:10 AM |
| Morales Mallory | Chief Accounting Officer | Mar 15, 2024 | Option Exercise | $1.62 | 4,344 | 7,037 | 6,778 | Mar 25, 2024, 09:04 AM |
| Morales Mallory | Chief Accounting Officer | Mar 22, 2024 | Buy | $2.55 | 393 | 1,000 | 8,278 | Mar 25, 2024, 09:04 AM |
| Morales Mallory | Chief Accounting Officer | Mar 21, 2024 | Buy | $2.72 | 1,107 | 3,009 | 7,885 | Mar 25, 2024, 09:04 AM |
| Neufeld Leah R | CHIEF PEOPLE OFFICER | Mar 15, 2024 | Option Exercise | $1.62 | 6,211 | 10,062 | 6,211 | Mar 21, 2024, 09:11 AM |
| Neufeld Leah R | CHIEF PEOPLE OFFICER | Mar 20, 2024 | Buy | $2.88 | 3,818 | 10,993 | 10,029 | Mar 21, 2024, 09:11 AM |
| Hall Brett Matthew | CHIEF SCIENTIFIC OFFICER | Mar 15, 2024 | Option Exercise | $1.62 | 6,211 | 10,062 | 338,896 | Mar 21, 2024, 09:06 AM |
| Hall Brett Matthew | CHIEF SCIENTIFIC OFFICER | Mar 20, 2024 | Buy | $2.86 | 7,000 | 20,020 | 345,896 | Mar 21, 2024, 09:06 AM |
| Bookman Michael | CHIEF LEGAL OFFICER, SECRETARY | Mar 15, 2024 | Option Exercise | $1.62 | 1,448 | 2,346 | 3,850 | Mar 19, 2024, 07:14 PM |
| BERMAN ANN E | Director | Mar 18, 2024 | Buy | $2.13 | 57,965 | 123,436 | 67,465 | Mar 19, 2024, 07:10 PM |
| Feinberg Peter | Director | Mar 18, 2024 | Buy | $2.38 | 50,000 | 119,058 | 61,766 | Mar 19, 2024, 07:04 PM |
| Feinberg Peter | Director | Mar 19, 2024 | Buy | $2.56 | 25,000 | 64,000 | 86,766 | Mar 19, 2024, 07:04 PM |
| Zeskind Benjamin J. | PRESIDENT AND CEO | Mar 19, 2024 | Buy | $2.77 | 20,000 | 55,326 | 2,281,852 | Mar 19, 2024, 06:59 PM |
| Cormorant Asset Management, LP | 10% Owner | Mar 15, 2024 | Sale | $2.14 | 400,000 | 856,400 | 3,295,273 | Mar 18, 2024, 05:59 PM |
| Cormorant Asset Management, LP | 10% Owner | Mar 14, 2024 | Sale | $3.72 | 509,091 | 1,892,603 | 3,859,098 | Mar 18, 2024, 05:59 PM |
| Zeskind Benjamin J. | PRESIDENT AND CEO | Dec 22, 2022 | Option Exercise | $3.01 | 2,500 | 7,525 | 2,261,852 | Dec 27, 2022, 08:14 AM |
| Hall Brett Matthew | CHIEF SCIENTIFIC OFFICER | May 25, 2022 | Buy | $3.92 | 2,551 | 10,000 | 332,685 | May 27, 2022, 04:09 PM |
| Bookman Michael | GENERAL COUNSEL AND SECRETARY | May 17, 2022 | Buy | $4.88 | 1,000 | 4,880 | 2,402 | May 18, 2022, 07:28 PM |
| KEATING LAURIE | Director | May 16, 2022 | Buy | $5.00 | 7,000 | 35,000 | 14,000 | May 17, 2022, 05:15 PM |
| Amin Biren | CFO, TREASURER | May 12, 2022 | Buy | $4.42 | 1,000 | 4,420 | 7,898 | May 12, 2022, 05:37 PM |
| Zeskind Benjamin J. | PRESIDENT AND CEO | Apr 12, 2022 | Option Exercise | $3.01 | 2,000 | 6,020 | 2,259,352 | Apr 14, 2022, 04:30 PM |
| Zeskind Benjamin J. | PRESIDENT AND CEO | Mar 23, 2022 | Buy | $8.02 | 3,000 | 24,060 | 2,257,352 | Mar 24, 2022, 04:39 PM |
| Hall Brett Matthew | CHIEF SCIENTIFIC OFFICER | Mar 23, 2022 | Buy | $7.91 | 1,050 | 8,305 | 330,134 | Mar 23, 2022, 06:38 PM |
| Barrett Scott | CHIEF MEDICAL OFFICER | Mar 22, 2022 | Buy | $7.49 | 900 | 6,737 | 7,563 | Mar 22, 2022, 06:49 PM |
| Feinberg Peter | Director | Mar 15, 2022 | Buy | $6.75 | 6,667 | 45,002 | 11,766 | Mar 16, 2022, 05:30 PM |
| BERMAN ANN E | Director | Mar 15, 2022 | Buy | $6.40 | 6,000 | 38,400 | 9,500 | Mar 15, 2022, 05:53 PM |
| Zeskind Benjamin J. | PRESIDENT AND CEO | Feb 28, 2022 | Option Exercise | $3.01 | 2,000 | 6,020 | 2,254,352 | Mar 01, 2022, 05:19 PM |
| Feinberg Peter | Director | Sep 20, 2021 | Buy | $24.44 | 4,750 | 116,114 | 5,099 | Sep 21, 2021, 05:53 PM |
| Feinberg Peter | Director | Sep 13, 2021 | Buy | $21.25 | 349 | 7,416 | 349 | Sep 15, 2021, 05:58 PM |
| Feinberg Peter | Director | Sep 13, 2021 | Buy | $21.51 | 5,750 | 123,697 | 392,242 | Sep 15, 2021, 05:58 PM |
| Zeskind Benjamin J. | PRESIDENT AND CEO | Sep 13, 2021 | Buy | $22.87 | 2,083 | 47,632 | 2,602,352 | Sep 14, 2021, 04:47 PM |
| Cormorant Asset Management, LP | Former 10% Owner | Aug 03, 2021 | Buy | $15.00 | 550,000 | 8,250,000 | 2,252,628 | Aug 05, 2021, 04:01 PM |
| Feinberg Peter | Director | Aug 03, 2021 | Buy | $15.00 | 291,667 | 4,375,005 | 476,568 | Aug 04, 2021, 06:06 AM |
| Zeskind Benjamin J. | President and CEO | Aug 03, 2021 | Buy | $15.00 | 2,098 | 31,470 | 2,600,269 | Aug 04, 2021, 06:06 AM |
| KEATING LAURIE | Director | Aug 03, 2021 | Buy | $15.00 | 7,000 | 105,000 | 7,000 | Aug 04, 2021, 06:06 AM |
| Hall Brett Matthew | Chief Scientific Officer | Aug 03, 2021 | Buy | $15.00 | 1,353 | 20,295 | 6,393 | Aug 04, 2021, 06:05 AM |
| CARPENTER ROBERT J | Director | Aug 03, 2021 | Buy | $15.00 | 325,000 | 4,875,000 | 1,148,839 | Aug 04, 2021, 06:05 AM |
| Bookman Michael | General Counsel and Secretary | Aug 03, 2021 | Buy | $15.00 | 1,402 | 21,030 | 1,402 | Aug 04, 2021, 06:05 AM |
| BERMAN ANN E | Director | Aug 03, 2021 | Buy | $15.00 | 3,500 | 52,500 | 3,500 | Aug 04, 2021, 06:04 AM |
| Barrett Scott | Chief Medical Officer | Aug 03, 2021 | Buy | $15.00 | 667 | 10,005 | 6,663 | Aug 04, 2021, 06:04 AM |
| Amin Biren | CFO, Treasurer | Aug 03, 2021 | Buy | $15.00 | 4,175 | 62,625 | 6,898 | Aug 04, 2021, 06:04 AM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Cormorant Asset Management, LP | 10% Owner | 04/01/2024 | 1,160,181 |
| Schall Thomas J. | Director | 03/22/2024 | 7,385 |
| Feinberg Peter | Director | 03/22/2024 | 63,713 |
| Brakewood Harold Eugene | Chief Business Officer | 03/22/2024 | 10,015 |
| Morales Mallory | Chief Accounting Officer | 03/15/2024 | 7,037 |
| Morales Mallory | Chief Accounting Officer | 03/22/2024 | 1,000 |
| Morales Mallory | Chief Accounting Officer | 03/21/2024 | 3,009 |
| Neufeld Leah R | CHIEF PEOPLE OFFICER | 03/15/2024 | 10,062 |
| Neufeld Leah R | CHIEF PEOPLE OFFICER | 03/20/2024 | 10,993 |
| Hall Brett Matthew | CHIEF SCIENTIFIC OFFICER | 03/15/2024 | 10,062 |
| Hall Brett Matthew | CHIEF SCIENTIFIC OFFICER | 03/20/2024 | 20,020 |
| Bookman Michael | CHIEF LEGAL OFFICER, SECRETARY | 03/15/2024 | 2,346 |
| BERMAN ANN E | Director | 03/18/2024 | 123,436 |
| Feinberg Peter | Director | 03/18/2024 | 119,058 |
| Feinberg Peter | Director | 03/19/2024 | 64,000 |
| Zeskind Benjamin J. | PRESIDENT AND CEO | 03/19/2024 | 55,326 |
| Cormorant Asset Management, LP | 10% Owner | 03/15/2024 | 856,400 |
| Cormorant Asset Management, LP | 10% Owner | 03/14/2024 | 1,892,603 |
| Zeskind Benjamin J. | PRESIDENT AND CEO | 12/22/2022 | 7,525 |
| Hall Brett Matthew | CHIEF SCIENTIFIC OFFICER | 05/25/2022 | 10,000 |
| Bookman Michael | GENERAL COUNSEL AND SECRETARY | 05/17/2022 | 4,880 |
| KEATING LAURIE | Director | 05/16/2022 | 35,000 |
| Amin Biren | CFO, TREASURER | 05/12/2022 | 4,420 |
| Zeskind Benjamin J. | PRESIDENT AND CEO | 04/12/2022 | 6,020 |
| Zeskind Benjamin J. | PRESIDENT AND CEO | 03/23/2022 | 24,060 |
| Hall Brett Matthew | CHIEF SCIENTIFIC OFFICER | 03/23/2022 | 8,305 |
| Barrett Scott | CHIEF MEDICAL OFFICER | 03/22/2022 | 6,737 |
| Feinberg Peter | Director | 03/15/2022 | 45,002 |
| BERMAN ANN E | Director | 03/15/2022 | 38,400 |
| Zeskind Benjamin J. | PRESIDENT AND CEO | 02/28/2022 | 6,020 |
| Feinberg Peter | Director | 09/20/2021 | 116,114 |
| Feinberg Peter | Director | 09/13/2021 | 7,416 |
| Feinberg Peter | Director | 09/13/2021 | 123,697 |
| Zeskind Benjamin J. | PRESIDENT AND CEO | 09/13/2021 | 47,632 |
| Cormorant Asset Management, LP | Former 10% Owner | 08/03/2021 | 8,250,000 |
| Feinberg Peter | Director | 08/03/2021 | 4,375,005 |
| Zeskind Benjamin J. | President and CEO | 08/03/2021 | 31,470 |
| KEATING LAURIE | Director | 08/03/2021 | 105,000 |
| Hall Brett Matthew | Chief Scientific Officer | 08/03/2021 | 20,295 |
| CARPENTER ROBERT J | Director | 08/03/2021 | 4,875,000 |
| Bookman Michael | General Counsel and Secretary | 08/03/2021 | 21,030 |
| BERMAN ANN E | Director | 08/03/2021 | 52,500 |
| Barrett Scott | Chief Medical Officer | 08/03/2021 | 10,005 |
| Amin Biren | CFO, Treasurer | 08/03/2021 | 62,625 |
Load More Insider Transactions
FUNDS WITH A POSITION IN IMMUNEERING CORP
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| BlackRock Inc. | 1,377,120 | 0.00010% | -34.34% | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 444,233 | 0.00034% | 2.66% | Other |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 100,000 | 0.00152% | -48.72% | Other |
CHANGE IN SHARES OUTSTANDING FOR IMMUNEERING CORP
STOCK BUYBACKS FOR IMMUNEERING CORP
Load More
Period of Report: 09/30/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
06/30/2023
2.16%
1Q
03/31/2023
10.68%
2Q
12/31/2022
10.83%
3Q
09/30/2022
10.88%
4Q
06/30/2022
10.91%
5Q
03/31/2022
11.03%
6Q
09/30/2021
60.04%
8Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR IMMUNEERING CORP
LOADING...